BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients

Blood

Volumn 87, Issue 11, 1996, Pages 4770-4779

  Verfaillie, Catherine M ^a   Bhatia, Ravi ^b   Miller, Wesley ^b   Mortari, Frank ^b   Roy, Vivek ^b   Burger, Scott ^b   McCullough, Jeff ^b   Stieglbauer, Kevin ^b   Dewald, Gordon ^b   Heimfeld, Shelly ^b   Miller, Jeffrey S ^b   McGlave, Philip B ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CYTARABINE; HYDROXYUREA;

ARTICLE; BONE MARROW TRANSPLANTATION; CELL SELECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; BONE MARROW; CELL COUNT; CELLS, CULTURED; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, AGGRESSIVE-PHASE; LEUKEMIA, MYELOID, CHRONIC-PHASE; NEOPLASM PROTEINS; PHILADELPHIA CHROMOSOME; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR STEM CELLS;

EID: 0029896896     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4770.bloodjournal87114770     Document Type: Article

References (59)

1. Fialkow PJ, Jacobson RJ, Papayannopoulou TH: Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63:125, 1977
2. Bakhshi A, Minowada J, Arnold A, Cossman J, Jensen JP, Whang-Peng J, Waldmann TA, Korsmeyer SJ: Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N Engl J Med 309:826, 1983
3. Jonas D, Lubbert M, Kawasaki ES: Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia. Blood 79:1017, 1992
4. Warzynski MJ, White C, Golightly MG, Steingart R, Otto RN, Podgurski AE, Johnson ML, Glynn P, Smith DE: Natural killer lymphocyte blast crisis of chronic myelogenous leukemia. Am J Hematol 32:279, 1989
5. Rowley JD: The Philadelphia chromosome translocation: A paradigm for understanding leukemia. Cancer 65:2178-2184, 1990
6. Bartram CR, deKlein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M: Translocation of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature 306:277, 1983
7. Kantarjian HM, Smith TL, McCredie KB, Keating MJ, Walters RS, Talpaz M, Hester JP, Bligham G, Gehan E, Freireich EJ: Chronic myelogenous leukemia: A multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 66:1326, 1985
8. Talpaz M, Kantarjian H, Kurzrock R, Trujilo JM, Gutterman JU: Interferon-alpha produces sustained cytogenetic response in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med 114:532, 1991
9. McGlave PB, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Kernan NA: Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program (NMDP). Blood 81:543, 1993
10. Snyder DS, McGlave PB: Treatment of chronic myelogenous leukemia with bone marrow transplantation. Hematol Oncol Clin North Am 4:5357, 1990
11. Weisdorf D, Haake R, Blazar R, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A: Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51:1197, 1991
12. Daley GQ, Goldman JM: Autologous transplant for CML revisited. Exp Hematol 21:734, 1993
13. McGlave PB, DeFabritiis P, Deisseroth A, Goldman J, Barnett M, Reiffers J, Simonsson B, Carella A, Aeppli D: Autologous transplant therapy for chronic myelogenous leukemia prolongs survival: Results from eight transplant centers. Lancet 343:1486, 1994
14. McGlave PB, Arthur D, Miller WJ, Lasky L, Kersey J: Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma. Bone Marrow Transplant 6:115, 1990
15. Barnett MJ, Eaves CH, Phillips GL, et al: Successful autografting in chronic myeloid leukemia after maintenance of marrow in culture. Bone Marrow Transplant 4:345, 1989
16. Coutinho LH, Testa NG, Chang J, Morgenstern G, Harrison C, Dexter TM: The use of cultured bone marrow cells in autologous transplantation. Prog Clin Biol Res 333:415, 1990
17. Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V. In vitro marrow purging in chronic myelogenous leukemia: Effect of mafosfamide and recombinant granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplant 8:265, 1991
18. Degliantoni G, Mangoni L, Rizzoli V: In vitro restoration of polyclonal hematopoiesis in a chronic myelogenous leukemia after in vitro treatment with 4-hydroperoxycyclophosphamide. Blood 65:753, 1985
19. Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I: Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on the percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells. Blood 85:3257, 1995
20. + cells present in autologous marrow of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplants in CML. Blood 83:3068, 1994
21. - peripheral blood stem cells (PBCS) effect timely trilineage engraftment in multiple myeloma (MM). Blood 86:293a, 1994 (suppl. abstr)
22. Verfaillie C, Blakolmer K, McGlave P: Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated BM stroma. J Exp Med 172:509, 1990
23. + cells that lack detectable T cell, B cell and myeloid antigens produce multiple colony forming cells when cultured with marrow stromal cells. J Exp Med 172:355, 1990
24. Brandt J, Baird N, Lu L, Srour E, Hoffman R: Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 82:1017, 1988
25. Baum CM, Weissman IL, Tsukamoto AS, Buckle A-M, Peault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804, 1992
26. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
27. - progenitor cells. Blood 77:1218, 1991
28. - population of bone marrow cells. Blood 76:674a, 1990 (abstr)
29. Srour EF, Zanjani ED, Cornetta K, Traycoff CM, Flake AW, Hedrick M, Brandt JE, Leemhuis T, Hoffman R: Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 82:3333, 1993
30. - primitive progenitors in human long term bone marrow culture. Blood 80:2181, 1992
31. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of DR antigen expression. Blood 79:1003, 1992
32. Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R: Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 81:801, 1993
33. +/CD381o population of chronic myeloid leukemia: An analysis using interphase fluorescence hybridization. Blood 86:737, 1995
34. Negrin R, Weissman I: Hematopoietic stem cells in normal and malignant states. Marrow Transplant Rev 2:23, 1992
35. Canellos GP: Clinical characteristics of the blast phase of chronic myelogenous leukemia. Hematol Oncol Clin North Am 4:359, 1990
36. Burrhoughs JM, Gupta P, Verfaillie CM: Soluble factors from the mouse fibroblast cell line M210-B4 support in vitro hematopoiesis. Exp Hematol 22:1095, 1994
37. Verfaillie CM: Direct stroma contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 79:2821, 1992
38. Verfaillie C, McGlave P: Leukemia inhibitory factor/human interleukin for DA cells: A growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors. Blood 77:263, 1991
39. Dewald GW, Broderick DJ, Tom WT, Hagstrom JE, Pierre RV: The efficacy of direct, 24 hour culture and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic disorders. Cancer Genet Cytogenet 18:1, 1984
40. Grosveld G, Verwoerd T, van Aghtenhoven T, de Klein A, Ramachandran KL, Heisterkamp N, Stam K, Groffen J: The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol 6:607, 1986
41. Ely P, Miller W: BCR/ABL mRNA detection following bone marrow transplantation for chronic myelogenous leukemia. Transplantation 52:1023, 1991
42. Dewald GW, Schad CR, Christensen ER, Tiede SL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM: The application of fluorescent in situ hybridization to detect MBCR/ABL fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71:7, 1993
43. Bedi A, Zehnbauer BA, Collector MI, Braber JP, Zicha MS, Sharkis SJ, Jones RJ: BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myelogenous leukemia. Blood 81:2898, 1993
44. + cells arising from hematopoietic progenitors in chronic myelogenous leukemia. Blood 83:1744, 1994
45. Carella AM, Podesta M, Grassoni F, Pungolino E, Pollicardo N, Raffo MR, Ferrero R, Benvenuto F, Figari O, Giordano D: Selective overshoot of Ph-negative blood hemopoietic cells after an intensive idarubicin-containing regimen and their repopulating capacity after reinfusion. Stem Cells 11:67, 1993 (suppl 3)
46. Lo Coco F, Mandelli F, Diverio D, Alimena G, De Fabritiis P, Meloni G, Cedrone M, Frontani M, Guerrasio A, Saglio G: Therapyinduced Ph suppression in chronic myeloid leukemia: Molecular and cytogenetic studies in patients treated with alpha-2a IFN, high-dose chemotherapy and autologous stem cell infusion. Bone Marrow Transplant 6:253, 1990
47. Kuss BJ, Sage RE, Shepherd KM, Hardingham J, Nicola M: High dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukemia. Leuk Lymph 10:73, 1993
48. - marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991
49. + marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 80:1693, 1992
50. + hematopoietic progenitor cells. J Hematother 3:145, 1994
51. Dunbar CE, Cottier-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, et al: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
52. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994
53. Weilbaecher K, Weissman I, Blume K, Heimfeld S: Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers. Blood 78:945, 1991
54. Hughes TP, Morgan GJ, Martiat P, Goldman JM: Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 77:874, 1991
55. Roth MS, Antin JH, Ash R, Gotlieb M, Silver SM, Ginsburg D: Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 79:276, 1992
56. Higano CS, Raskind WH, Singer JW: Use of α-interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation. Blood 80:1437, 1992
57. Charak BS, Agah R, Gray D, Mazumder A: Interaction of various cytokines with interleukin 2 in the generation of killer cells from human bone marrow: Application in purging of leukemia. Leuk Res 15:801, 1991
58. Mackinnon S, Hows JM, Goldman JM: Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia. Blood 76:2037, 1990
59. Cervantes P, McGlave PB, Verfaillie CM, Miller JS: Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture. Blood 87:2476, 1996